IUIS-Frontiers Webinar Series on COVID-19

The situation that we are facing with the COVID-19 pandemic is unprecedented. The IUIS is collaborating with Frontiers and launching a series of weekly expert commentaries and scientific webinars to accelerate the development of novel diagnostics, therapeutics and vaccines. Tune in to the IUIS-Frontiers scientific webinars!

Webinar on June 08

Respiratory immunity and COVID-19 

Date: June 08, 2020
Time: 18:00 (CEST)

Donna Farber will discuss the development of lung-localized immune responses and the role of tissue resident memory T cells in protective immunity to respiratory viruses, in mouse models of influenza infection and in human lungs,  including recent findings on the impact of age on human lung immunity.  These concepts will be discussed in the context of respiratory immunity in SARS-CoV2 infection and our studies identifying potential immune correlates of disease severity in COVID-19.
Watch the interview now and join the live webinar for more insights!

Presenter: Donna Farber

Donna  Farber is the George H Humphreys, II Professor of Surgical Sciences (in Surgery) and Professor of Microbiology and Immunology at Columbia University. The focus of Dr. Farber’s research is on adaptive immunity, particularly to virus infections and how T cell differentiate and generate long-term immunological memory in diverse tissues sites.  

Dr. Farber’s laboratory identified subsets of tissue-resident memory T cells in the lung that mediate protective immunity to respiratory virus infection and has led an initiative in translational immunology to dissect human immune responses in tissues throughout the body, in multiple mucosal and lymphoid tissues from individual organ donors of all ages.  

Moderator: Henry Mwandumba

Henry Mwandumba is Professor of Immunology and Infectious Diseases at the University of Malawi College of Medicine and Deputy Director of the Malawi Liverpool Wellcome Trust Clinical Research Programme (MLW) in Blantyre, Malawi. His research focuses on understanding the effects of HIV-1 infection on lung immunity and predisposition to respiratory infections, particularly tuberculosis. He is President of the Federation of African Immunological Societies (FAIS) and was awarded the 2019 Royal Society Africa Prize.

Webinar on June 15

Understanding Infection and Immunity of SARS-CoV-2: from diagnostics to therapies for COVID-19

Date: June 15, 2020
Time: 11:00 (CEST)

SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) is the causative agent of the ongoing Coronavirus Disease 2019 (COVID-19) pandemic. Alongside investigations into the virology of SARS-CoV-2, understanding the fundamental physiological and immunological processes underlying the clinical manifestations of COVID-19 is vital for the identification and rational design of effective therapies. In this webinar, Lisa Ng will provide an overview of the pathophysiology of SARS-CoV-2 infection. She will describe its interaction with the immune system and the subsequent contribution of dysfunctional immune responses to disease progression. These will provide important insights in designing useful diagnostics and therapies.
Watch the interview now and join the live webinar for more insights!

Presenter

Since starting her own research lab at the Singapore Immunology Network (SIgN), Lisa Ng is currently a Senior Principal Investigator. The research interest of her group focuses on the immune responses of arthrogenic arboviruses that are epidemic or highly endemic in the tropical region.
Her team made several key important findings to move the human immunology field forward in controlling chikungunya virus and Zika virus infections.
For her previous work and contributions to SARS, she was voted “Most Inspiring Woman” at the Great Women of Our Time Awards for Science and Technology in 2005. In recognition of her meritorious research and development efforts on Asia’s infectious diseases, she was conferred the highly prestigious ASEAN “International Young Scientist and Technologist Award” in 2008.

Moderator

Faith Osier is the President of the International Union of Immunological Societies (IUIS), an Official #TOGETHERBAND Ambassador for the UN Sustainable Development Goal 3: Good Health & Well-being and a 2018 TED Fellow.


On-demand Webinars

Sharon Lewin and Katherine Kedzierska: COVID-19 in Australia: Being prepared and understanding the role of cellular immune responses 

What role do cellular immune responses play in squashing the curve of COVID-19 infections? Sharon Lewin and Katherine Kedzierska show how immunity to SARS-CoV2 has demonstrated the breadth of concomitant immune responses associated with recovery in patients with mild to moderate COVID-19 requiring hospitalisation. Their study indicates that robust multi-factorial immune responses can be elicited towards the newly-emerged SARS-CoV-2 and early adaptive immune responses might correlate with better clinical outcomes.
Sharon Lewin is the inaugural director of the Peter Doherty Institute for Infection and Immunity. Katherine Kedzierska is Laboratory Head in Department of Microbiology and Immunology, at the Peter Doherty Institute for Infection and Immunity.
The webinar is moderated by Roslyn Kemp, Past President of the New Zealand Society for Oncology and Secretary-General of IUIS.

Mihai Netea: Trained immunity and BCG vaccination: a tool against COVID-19?

What do we know about the adaptive characteristics of innate immune responses? Does BCG induce long-term changes in innate immune cells? What are the non-specific effects of BCG vaccination on other infections? Can the BCG-induced trained immunity be harnessed against COVID-19?
Mihai Netea heads the division of Experimental Medicine, Department of Internal Medicine, Nijmegen University Nijmegen Medical Center. He is mainly interested in understanding the factors influencing the variability of human immune responses, the biology of sepsis and immunoparalysis in bacterial and fungal infections, and the study of the memory traits of innate immunity.
The webinar is moderated by Faith Osier, President of the International Union of Immunological Societies (IUIS).

Andreas Radbruch: Adaptive Immunity in COVID-19

Adaptive Immunity: Memory, Protection and Immunopathology in COVID-19: What do we know about the adaptive immune reaction to Sars-CoV-2? Why do humans react so heterogeneously to Sars-CoV-2? Does the adaptive immune system provide protection and for how long? How can we challenge the system with a vaccine to establish longlasting, efficient immunity?
Andreas Radbruch, Scientific Director of the DRFZ and Professor for Experimental Rheumatology at the Medical Faculty of the Humboldt University of Berlin, shares his insights. The webinar is moderated by Rita Carsetti (Head of the Diagnostic Immunology Unit and of the B cell pathophysiology Research Unit of the Bambino Gesù Children Hospital IRCCS in Rome).

Rachel Humphrey: What cancer immunologists are doing about COVID-19

What are physicians and scientists seeing in their COVID-19-infected patients and in their own personal scientific explorations? What are the ongoing hypotheses that drive the emerging clinical studies, and what can we say about the rapid evolution of medicine, in light of their ongoing work? Rachel Humphrey, shares her insights. Rachel is a medical oncologist, who is currently serving as Head of Research and Development for TIO Bioventures. The webinar is moderated by Miriam Merad, Vice-President of the IUIS.

Eleanor Fish: Global outbreaks – Interferons as 1st responders

Can antivirals that target the host and not the virus improve outcomes for COVID-19 patients? Professor Eleanor Fish from the University of Toronto showed that treatment with interferon-alpha was beneficial in patients with SARS, and now shares early data on COVID-19.

The webinar is moderated by Juan-Carlos Zuniga-Pflücker, the Chair of the Department of Immunology at the University of Toronto.

Giuseppe Ippolito: The Global Scientific Response to COVID-19

Giuseppe Ippolito, Scientific Director at the National Institute for Infectious Diseases in Rome, Italy, shares his opinion on why policy responses to the coronavirus pandemic must be based on scientific evidence – and why policymakers must invest in science to be prepared for future infectious diseases.

The webinar is moderated by Rita Carsetti, Head of the Diagnostic Immunology Unit and of the B cell pathophysiology Research Unit of the Bambino Gesù Children Hospital IRCCS in Rome.

Rino Rappuoli on COVID-19 Vaccines

How long will it really take to develop a vaccine for COVID-19, and how is science speeding up the process? Rino Rappuoli, Chief Scientist and Head of Research & Development at GlaxoSmithKline, shares his insights as a world expert in vaccine development.

The webinar is moderated by Faith Osier, President of the International Union of Immunological Societies (IUIS).


Frontiers Coronavirus Knowledge Hub

A global challenge like the current COVID-19 pandemic can only be defeated when research results are rapidly and openly shared and all stakeholders work together – scientists, health workers, publishers, funders, policymakers, and government officials.

The Frontiers Coronavirus Knowledge Hub provides an up-to-date source of trusted information and analysis on COVID-19 and coronaviruses, including the latest research articles, information, and commentary from our world-class scientific community.


Stay up to date!

By subscribing to the IUIS newsletter you will receive all information about the next webinars and latest updates on immunology.